UA91693C2 - Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to madulation of the dopamine d3 receptor - Google Patents

Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to madulation of the dopamine d3 receptor

Info

Publication number
UA91693C2
UA91693C2 UAA200705274A UAA200705274A UA91693C2 UA 91693 C2 UA91693 C2 UA 91693C2 UA A200705274 A UAA200705274 A UA A200705274A UA A200705274 A UAA200705274 A UA A200705274A UA 91693 C2 UA91693 C2 UA 91693C2
Authority
UA
Ukraine
Prior art keywords
fluorinated
alkyl
cycloalkyl
rand
dopamine
Prior art date
Application number
UAA200705274A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Карла Дресхер
Андреас ХАУПТ
Лилиана УНГЕР
Шон К. ТЕРНЕР
Вилфрид Брайе
Роланд ГРАНДЕЛЬ
Кристоф Генри
Original Assignee
Эбботт Гмбх & Ко. Кг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эбботт Гмбх & Ко. Кг filed Critical Эбботт Гмбх & Ко. Кг
Priority claimed from PCT/EP2005/011091 external-priority patent/WO2006040178A1/en
Publication of UA91693C2 publication Critical patent/UA91693C2/en

Links

Abstract

The present invention relates to aromatic compounds of the formula (I), wherein Ar is phenyl or an aromatic 5-or 6-membered C-bound heteroaromatic radical, wherein Ar may carry 1 radical Rand wherein Ar may also carry 1 or 2 radicals R; X is N or CH; Y is O, S, -CH=N-, -CH=CH- or -N=CH-; A is CHO or S; E is CRRor NR; Ris C-C-alkyl, C-C-cycloalkyl, C-C-cycloalkylmethyl, C-C-alkenyl, fluorinated C-C-alkyl, fluorinated C-C-cycloalkyl, fluorinated C-C-cycloalkylmethyl, fluorinated C-C-alkenyl, formyl or C-C-alkylcarbonyl; Ris H, C-C-alkyl, C-C-cycloalkyl, C-C-alkenyl, fluorinated C-C-alkyl, fluorinated C-C-cycloalkyl, or Rand Rtogether arc (CH)with n being 2 or 3, or Rand Rtogether are (CH)with n being 2 or 3; Rand Rare independently of each other H, CH, CHF, CHFor CF; Ris H or C-C-alkyl; R, Rindependently of each other are selected from H, C-C-alkyl and fluorinated C-C-alkyl; and the physiologically tolerated acid addition sails thereof. The invention also relates to the use of a compound of the formula T or a pharmaceutically acceptable salt thereof for preparing a pharmaceutical composition for the treatment of a medical disorder susceptible to treatment with a dopamine Dreceptor ligand.
UAA200705274A 2004-10-14 2005-10-14 Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to madulation of the dopamine d3 receptor UA91693C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61877604P 2004-10-14 2004-10-14
PCT/EP2005/011091 WO2006040178A1 (en) 2004-10-14 2005-10-14 Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to madulation of the dopamine d3 receptor

Publications (1)

Publication Number Publication Date
UA91693C2 true UA91693C2 (en) 2010-08-25

Family

ID=52011544

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200705274A UA91693C2 (en) 2004-10-14 2005-10-14 Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to madulation of the dopamine d3 receptor

Country Status (1)

Country Link
UA (1) UA91693C2 (en)

Similar Documents

Publication Publication Date Title
NO20003561D0 (en) Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
NO20055655D0 (en) Use of azetidinecarboxamide derivatives in therapy
EP1369418A4 (en) Quinazoline derivatives
CA2440037A1 (en) Benzimidazole derivatives for modulating the rage receptor
MY142551A (en) Substituted diaryl heterocycles, process for their preparation and their use as medicaments
MXPA04009784A (en) Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors.
MXPA05000715A (en) Novel inhibitors of kinases.
NO20052914L (en) Therapeutic compounds
ZA200501098B (en) Novel use of benzothiazole derivatives
RU2007116987A (en) NEW COMPOUNDS
JP2006501201A5 (en)
TW200628437A (en) Aminoindane dopamine D3 receptor antagonists
MX2022015703A (en) 4-oxo-3,4-dihydroquinazolinon compounds for the treatment of braf-associated diseases and disorders.
TW200626571A (en) Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
EP0937715A4 (en) Tetrahydrobenzindole compounds
WO2022261240A3 (en) Dimethoxyphenylalkylamine activators of serotonin receptors
RU2003128984A (en) CARBAMATE DERIVATIVES FOR USE FOR TREATMENT OF PAIN
HK1106494A1 (en) Aminomethyl substituted bicyclic aromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
WO2003018515A3 (en) Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
KR920016418A (en) NMDA antagonist
UA91693C2 (en) Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to madulation of the dopamine d3 receptor
CA2523253A1 (en) Methyl indoles and methyl pyrrolopyridines as alpha-1 adrenergic agonists
CR20230218A (en) New indazole acetylene derivatives
TW200509915A (en) Novel oxazoles, their manufacture and use as pharmaceutical agents
WO2023044315A3 (en) Kca3.1 inhibitors for podocyte protection